Skip to navigation

Investor Home

Corporate Profile
SteadyMed Therapeutics, Inc. is a Specialty Pharmaceutical Company. SteadyMed leverages its PatchPump platform to develop its own therapeutic portfolio and partners to optimize the delivery of high volume (greater than two mL), high value, small molecule or biologic drugs.

Our family of PatchPumps can be customized to deliver liquid drugs, including biologics, with a wide range of volumes and viscosities, in a consistent and controllable manner. ...
Featured Reports
There are currently no items available.
Recent NewsMORE 
August 11, 2017
SteadyMed Reports Second Quarter 2017 Financial Results and Provides Corporate Update
August 09, 2017
SteadyMed to Present at the 2017 Wedbush PacGrow Healthcare Conference
July 31, 2017
SteadyMed Appoints Jeff Myers M.D. Ph.D. Vice President of Medical Affairs
Stock QuoteMORE 
STDY (Common Stock)
Exchange :NASDAQ GS (US Dollar)
Financial Status IndicatorN
Price :$6.00
Change (%) : Stock is Down 0.25 (4.00%)
Volume :3,969
Data as of 08/23/17 3:59 p.m. ET
Minimum 20 minute delay
Event CalendarMORE 
August 2017?
Calendar Help
This calendar contains six months of past and future company related information, which may include press releases, SEC filings, calendar events and more. Dates containing information are indicated by a colored background. You may hover your mouse over a date that contains an event to reveal the event or events taking place on that day including a link to additional information. This calendar requires JavaScript to be installed and activated on your browser.
Calendar Icon Legend:
Analyst Meeting
Conference Presentation
Corporate Conference Call
Custom Events
Earnings Conference Call
Earnings Release
Financial Reports
Mergers & Acquisition Announcement
Guidance Announcement
Other Corporate
Sales Call/Presentation
Sales Release
Shareholders Meeting
News Release
SEC Filings
52 Week High
Receive E-mail Alerts E-mail Alert Icon
Sign up to receive e-mail alerts whenever SteadyMed Therapeutics Inc posts new information to the site. Just enter your e-mail address and click Submit.
Data provided by Nasdaq. Minimum 15 minutes delayed. View Attributions and Sources

E-mail Alerts RSS Printer Friendly Version E-mail this page Share Page